We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease

By LabMedica International staff writers
Posted on 29 Apr 2025

Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. More...

There is a growing need to identify this risk from birth to enable preventative measures. Now, the umbilical cord may serve as a tool for doctors to predict which children are more likely to face long-term health problems, such as diabetes, stroke, and liver disease. DNA changes found in cord blood could provide early insights into which infants are at higher risk, paving the way for earlier and potentially life-saving interventions, according to research presented at Digestive Disease Week (DDW) 2025.

Researchers at Duke University Health System (Durham, NC, USA) utilized a novel genetic tool to analyze umbilical cord blood from 38 children who were part of the Newborn Epigenetics Study, a long-term birth cohort study. They focused on identifying changes in chemical tags—known as methyl groups—on the infants’ DNA that regulate gene activity. When these changes occur in critical areas of DNA, called imprint control regions, their effects can persist from fetal development into later life. The research team then compared the DNA changes with health data collected when the children reached ages 7 to 12. This data included body mass index, liver fat levels, alanine transaminase (ALT) — a marker of liver inflammation or damage, triglyceride levels, blood pressure, and waist-to-hip ratio.

The team identified several DNA regions where changes were linked to metabolic dysfunction later in childhood. For instance, alterations in the TNS3 gene were associated with liver fat, ALT levels, and waist-to-hip ratio, while changes in genes such as GNAS and CSMD1 were linked to blood pressure, waist-to-hip ratio, and ALT. Although the sample size was small, the researchers believe the findings are promising and warrant further exploration. A larger follow-up study is already underway. While these findings do not establish a direct cause-and-effect relationship between the genetic changes and disease, they highlight potential biological pathways that warrant further investigation.

“These epigenetic signals are laid down during embryonic development, potentially influenced by environmental factors such as nutrition or maternal health during pregnancy,” said co-author Cynthia Moylan, MD, associate professor of medicine, division of gastroenterology, at Duke University Health System. “If validated in larger studies, this could open the door to new screening tools and early interventions for at-risk children.”


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Epstein-Barr Virus Test
Mononucleosis Rapid Test
New
TRAcP 5b Assay
TRAcP 5b (BoneTRAP) Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.